CSOP Hang Seng Biotech ETF (03174.HK) Fell 0.50% to 3.190

Newtimespace News, as of 11:16 on May 20, CSOP Hang Seng Biotech ETF (03174.HK) was quoted at HKD 3.190, down 0.50%. The ETF opened at HKD 3.200, with a high of HKD 3.232 and a low of HKD 3.188. The latest Net Asset Value (NAV) per unit is HKD 3.215, with a premium rate of -0.28%. The asset size is approximately HKD 816 million.

CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotechnology Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to track the overall performance of the 30 largest biotechnology companies listed in Hong Kong that are eligible for Stock Connect trading. Its constituent stocks cover four major business sub-categories: pharmaceuticals, biotechnology, pharmaceutical distribution, and medical equipment and supplies, focusing on core biotechnology areas such as innovative drugs, CXO, and medical devices. It provides investors with a high-purity tool for concentrated investment in leading Hong Kong-listed biotechnology companies and capturing the development trends of pharmaceutical innovation.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.